Stanford Center for Clinical Research: Clinical Research Educational Session

When:
April 30, 2015 @ 9:00 am – 12:30 pm
2015-04-30T09:00:00-07:00
2015-04-30T12:30:00-07:00
Where:
MSOB X303
Stanford University
1265 Welch Road, Stanford, CA 94305
USA
Cost:
Free
Contact:
Department of Medicine
Stanford Center for Clinical Research: Clinical Research Educational Session @ MSOB X303 | Stanford | California | United States

Clinical Research Session
Presented by the Stanford Center for Clinical Research within the Department of Medicine and the Department of Psychiatry and Behavioral Sciences

Date: Thursday, April 30 from 9:00am – 12:30pm in MSOB X303
Alternate session available: Thursday, April 30 from 2:00pm – 5:30pm in Alway M106

The mission of the Stanford Center for Clinical Research includes offering educational
resources, training, and support for Investigators and Staff. We have brought in a highly
experienced clinical research educator, Lisa Zimmerman, to provide you with a solid foundation in Good Clinical Practices. Topics include:

  • What is Informed Consent? More than just a signature!
  • What is ALCOA and why is it important?
  • Implications of GCP issues – how can we avoid them?

Session is open to investigators and research staff. In-person attendance is limited to 40. Live web-broadcast will be available. Click here to register.

Featured  Speaker: Lisa Zimmerman
Lisa Zimmerman is an accomplished professional with more than 21 years of experience in the pharmaceutical and device industry, with the last 15 years having been spent in senior leadership and executive roles at Pozen Inc., Duke Clinical Research Institute (DCRI), and ClinTrials Research. Ms. Zimmerman’s expertise includes developing the strategy and vision for Quality, Regulatory and Clinical programs.

Ms. Zimmerman’s successes include the development and implementation of Regulatory Affairs and Quality programs for both drug and devices at DCRI and the Regulatory Compliance/Quality and Clinical Programs at Pozen, Inc. In addition, Ms. Zimmerman was responsible for the operational execution of clinical development of Pozen’s pipeline. As a result Ms. Zimmerman has been instrumental in the management of three programs that have led to NDA approvals and one recent NDA submission. Lisa’s spare time has been spent in various teaching roles for Clinical Research programs as well as speaking at conferences on a variety of topics regarding the implementation of programs and strategies for drugs and devices.